Manufacturing execution system solutions have the potential
to improve productivity and simplify compliance within the
pharmaceutical manufacturing industry. However, factors such as
cost and lack of specialist expertise have proven a barrier to many
small and mid-sized pharmaceutical companies. Siobhan Fleming,
Business Development Executive and Manufacturing Software
Specialist at LZ Lifescience, discusses the role of MES solutions
in the pharmaceutical sector, typical barriers to adoption and the
increasing use of the technology as it becomes more accessible to a
wider part of the industry.
https://international-pharma.com/wp-content/uploads/2016/07/Man-2-MES.pdf
Current Edition
Current Edition
Subsection - CDMO
Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.
Continue readingSubsection - Injectables
Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.
Continue readingSubsection - Neurodegenerative Diseases
Exploring emerging approaches to neurodegenerative disease research and treatment.
Continue readingSubsection - Nasal & Pulmonary
Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.
Continue reading
MES Adoption in Pharmaceutical Manufacturing – A Changing Landscape
